States Target Mylan (MYL) Exec Malik in Generic Drug-Collusion Probe - Bloomberg
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- S&P 500, Nasdaq fall as investors juggle earnings, Mideast risks and tariffs
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil retreats from above $100, still set for weekly rise on Middle East escalation
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- Meta’s new seller app hits eBay where it hurts most
Expanded Generic Collusion Probe Creates 'Substantial Headline Risk' for Mylan (MYL) - Wells Fargo
October 31, 2017 12:33 PM EDTWells Fargo analyst David Maris weighed in on Mylan (NASDAQ: MYL) following news company President Rajiv Malik is one of two senior generic drug company executives to be individually targeted by dozens of states, according to a statement issued today from Connecticut Attorney... More
Mylan (MYL) Investigations Should Be 'Very Manageable' - Cowen
October 31, 2017 12:21 PM EDTCowen analyst Ken Cacciatore weighed in on Mylan (NASDAQ: MYL) amid news the ongoing antitrust investigation by the Department of Justice and various civil lawsuits from multiple States could be expanded.
Cacciatore said whatever the outcome of the many investigations, "it should be very... More
Mylan (MYL) Issues Statement in Response to Announcement of Proposed Amendments to Civil Complaint
October 31, 2017 12:04 PM EDTMylan N.V. (NASDAQ: MYL) provided the following statement in response to the announcement of proposed amendments to the civil complaint by various states' attorneys general in multi-district litigation pending in the U.S. District Court for the Eastern District of Pennsylvania against Mylan and 17... More
